News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,030 Results
Type
Article (39154)
Company Profile (283)
Press Release (648593)
Section
Business (203905)
Career Advice (1996)
Deals (35373)
Drug Delivery (89)
Drug Development (80852)
Employer Resources (168)
FDA (16099)
Job Trends (14808)
News (344648)
Policy (32450)
Tag
Academia (2530)
Alliances (49186)
Alzheimer's disease (1262)
Approvals (16061)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11582)
Biotechnology (200)
Breast cancer (189)
Cancer (1375)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64707)
Collaboration (485)
Compensation (262)
COVID-19 (2541)
C-suite (110)
Data (1391)
Diabetes (176)
Diagnostics (6170)
Earnings (84896)
Employer resources (146)
Events (110018)
Executive appointments (397)
FDA (16786)
Funding (431)
Gene therapy (195)
GLP-1 (599)
Government (4333)
Healthcare (18697)
Infectious disease (2634)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16344)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7862)
Lung cancer (198)
Manufacturing (207)
Medical device (13213)
Medtech (13218)
Mergers & acquisitions (19196)
Metabolic disorders (460)
Neuroscience (1583)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1700)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (120)
People (56464)
Phase I (20127)
Phase II (28498)
Phase III (21240)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5890)
Regulatory (21679)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1468)
Startups (3562)
United States (15235)
Vaccines (564)
Weight loss (182)
Date
Today (127)
Last 7 days (588)
Last 30 days (2375)
Last 365 days (35288)
2024 (35129)
2023 (40076)
2022 (51173)
2021 (55714)
2020 (54086)
2019 (46542)
2018 (35020)
2017 (32110)
2016 (31480)
2015 (37554)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (196)
Asia (37276)
Australia (6087)
California (3830)
Canada (1457)
China (308)
Colorado (172)
Connecticut (178)
Europe (79834)
Florida (537)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (634)
Massachusetts (2973)
Michigan (175)
Minnesota (291)
New Jersey (1108)
New York (1091)
North Carolina (743)
Northern California (1700)
Ohio (146)
Pennsylvania (928)
South America (1092)
Southern California (1468)
Texas (554)
Utah (108)
Washington State (401)
688,030 Results for "agenus inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, is pleased to announce the appointment of Dr. Jennifer Buell to its Board of Directors, on June 11, 2024, effective immediately.
June 17, 2024
·
4 min read
BioMidwest
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
Ligand Pharmaceuticals Incorporated and Agenus Inc. announced that the companies have entered into a royalty financing agreement to support Agenus’ key development initiatives in the ongoing BOT/BAL clinical development program.
May 7, 2024
·
11 min read
Regulatory
Future of Agenus’ Immunotherapy Combo Uncertain as FDA Discourages Accelerated Approval in CRC
Agenus is now looking for alternative pathways to initiate a Phase III trial for BOT/BAL, including potential partnerships.
July 18, 2024
·
2 min read
·
Tristan Manalac
Business
Agenus Reports First Quarter 2024 Results
Agenus Inc., a leader in discovering and developing novel immunological agents to treat various cancers, announced results for the first quarter 2024.
May 7, 2024
·
9 min read
Genetown
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 24, 2024
Agenus Inc. announced that the Compensation Committee of Agenus’ Board of Directors granted inducement awards to Eric Olson, in connection with his appointment as Head of Regulatory.
May 24, 2024
·
1 min read
Deals
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immunology-based therapies for cancer, received notice from NASDAQ on April 30, 2024, that the Company has regained compliance with the $1.00 minimum bid price requirement set forth in NASDAQ Listing Rule 5550(a)(2).
May 1, 2024
·
1 min read
Press Releases
Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership With Agenus
December 12, 2024
·
2 min read
Press Releases
Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs
December 5, 2024
·
4 min read
Press Releases
Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment
November 27, 2024
·
4 min read
Business
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
Agenus Inc. today announced the Company will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.
April 23, 2024
·
2 min read
1 of 68,803
Next
